June 07, 2022
2 min watch
Save
VIDEO: Take comorbidities into consideration with patients with immune-mediated disease
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CLEVELAND — In this video, M. Elaine Husni, MD, MPH, stressed the importance of taking into consideration the comorbidities of a patient with immune-mediated disease.
“We are understanding a lot more about how comorbidities are affecting patients with immune-mediated diseases,” Husni, of the department of rheumatic and immunologic disease at the Cleveland Clinic, said.
Husni outlined how comorbidities such as elevated BMI, metabolic syndrome and mental illness can affect how a patient experiences IMIDs and how clinicians can choose therapies.
Published by:
Sources/Disclosures
Collapse
Source:
M. Elaine Husni, MD, MPH
Disclosures:
Husni reports being is a consultant for AbbVie, Novartis, Lilly, Pfizer and Janssen.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.